Acute myocardial infarction in the elderly: Treatment strategies and 28-day-case fatality from the MONICA/KORA myocardial infarction registry

Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
Ute AmannC Meisinger

Abstract

Aim of this observational study was to analyze today's real-life treatment strategies in elderly patients with an acute myocardial infarction (AMI) and to assess the association between 28-day-case fatality and invasive strategy (percutaneous coronary intervention/coronary artery bypass grafting). Elderly patients increasingly constitute a large proportion of the AMI population. The present study is an analysis of all patients aged 75-84 years, who were enrolled in the German population-based MONICA/KORA MI registry between 2009 and 2012 and who were defined as nonfatal at least 24 hours surviving AMI cases according to MONICA definition. Multivariable logistic regression analyses were conducted for the total study population and stratified by type of AMI (ST-segment elevation MI [STEMI], Non-ST-segment elevation MI [NSTEMI], and bundle branch block [BBB]). Out of the 1,191 elderlies, 61.9% were treated invasively. In the multivariable analysis, the odds ratio (OR) for 28-day-case fatality in patients treated with invasive versus conservative strategy was 0.43 (95% CI 0.27-0.69). Stratified analyses revealed an OR of 0.27 (95% CI 0.13-0.56) for patients with NSTEMI. In patients with STEMI or BBB also a positive trend for invasi...Continue Reading

References

Dec 20, 2005·International Journal of Cardiology·Christa MeisingerHannelore Löwel
Nov 6, 2007·European Heart Journal·Timm BauerUNKNOWN Acute Coronary Syndromes Registry (ACOS) Investigators
Jan 9, 2008·Journal of the American Geriatrics Society·Andreas W SchoenenbergerUNKNOWN Acute Myocardial Infarction in Switzerland Plus Investigators
Jan 6, 2009·The American Journal of Cardiology·Palak ShahHoward A Cooper
Jan 30, 2009·European Heart Journal·François SchieleUNKNOWN Reseau de Cardiologie de Franche Comte
Sep 8, 2010·The American Journal of Cardiology·Gian Battista DanziDavid Antoniucci
Mar 26, 2011·Cardiovascular Drugs and Therapy·Amelia CarroJuan Carlos Kaski
Nov 29, 2011·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Harald RittgerJohannes Rieber
Feb 16, 2012·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Harald RittgerUwe Zeymer
Mar 12, 2013·The New England Journal of Medicine·Paul W ArmstrongUNKNOWN STREAM Investigative Team
Jul 10, 2013·The American Journal of Medicine·Jennifer TjiaRobert J Goldberg
Jul 28, 2013·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Els H VandecasteeleMarc J Claeys
Apr 20, 2014·Age and Ageing·Christopher E D SaundersonChristopher P Gale
May 28, 2014·Heart·Mauro Di BariUNKNOWN Acute Myocardial Infarction in Florence 2 (AMI Florence-2) Working Group
Feb 6, 2015·Clinical Interventions in Aging·Berglind LibunganJohan Herlitz

❮ Previous
Next ❯

Citations

Mar 21, 2016·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Justin Cox, Timothy D Henry

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

© 2021 Meta ULC. All rights reserved